Get the Stockscreener App
7.24
0.14%
0.010
After Hours:
7.24
Aclarion Inc stock is traded at $7.24, with a volume of 20,603.
It is up +0.14% in the last 24 hours and down -15.79% over the past month.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
See More
Previous Close:
$7.23
Open:
$7.24
24h Volume:
20,603
Relative Volume:
0.17
Market Cap:
$4.22M
Revenue:
$49,300
Net Income/Loss:
$-6.27M
P/E Ratio:
-0.7965
EPS:
-9.09
Net Cash Flow:
$-5.38M
1W Performance:
-7.54%
1M Performance:
-15.79%
6M Performance:
+1.97%
1Y Performance:
+41.88%
1-Day Range:
$7.23
$7.285
1-Week Range:
$7.00
$7.8299
52-Week Range:
$0.7425
$562.68
Aclarion Inc Stock (ACON) Company Profile
Name
Aclarion Inc
Sector
Industry
Phone
833 275 2266
Address
8181 ARISTA PLACE, BROOMFIELD
Compare ACON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
7.24 | 4.21M | 49,300 | -6.27M | -5.38M | -9.09 |
|
VEEV
Veeva Systems Inc
|
295.75 | 48.33B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
71.78 | 12.73B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
99.83 | 8.07B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
52.54 | 10.22B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.11 | 6.93B | 906.14M | -52.62M | 89.62M | -0.3621 |
Aclarion Inc Stock (ACON) Latest News
Visualizing Aclarion Inc. stock with heatmapsQuarterly Portfolio Summary & AI Enhanced Execution Alerts - newser.com
How to build a dashboard for Aclarion Inc. Equity Warrant stock2025 Investor Takeaways & Daily Technical Stock Forecast Reports - newser.com
Is Aclarion Inc. (IT20) stock vulnerable to rate hikesJuly 2025 Drop Watch & Comprehensive Market Scan Insights - newser.com
How Aclarion Inc. stock compares to market leaders2025 Big Picture & Daily Stock Trend Watchlist - newser.com
Aclarion Inc. stock prediction for this week2025 Volume Leaders & Daily Price Action Insights - newser.com
Can machine learning forecast Aclarion Inc. recoveryQuarterly Growth Report & Free Expert Verified Stock Movement Alerts - newser.com
Is Aclarion Inc. Equity Warrant stock supported by strong cash flowsQuarterly Profit Summary & Daily Volume Surge Signals - newser.com
Custom strategy builders for tracking Aclarion Inc. Equity WarrantJuly 2025 Setups & Safe Capital Allocation Plans - newser.com
Signal strength of Aclarion Inc. Equity Warrant stock in tech scannersForecast Cut & AI Enhanced Trade Execution Alerts - newser.com
Why Aclarion Inc. Equity Warrant stock appeals to analystsJuly 2025 Drop Watch & Capital Efficient Trade Techniques - newser.com
Multi asset correlation models including Aclarion Inc. Equity WarrantTrade Volume Summary & Long-Term Growth Portfolio Plans - newser.com
How interest rate cuts could boost Aclarion Inc. stockJuly 2025 Institutional & Stepwise Swing Trade Plans - newser.com
How Aclarion Inc. (IT20) stock responds to job market shiftsMarket Trend Summary & Smart Allocation Stock Tips - newser.com
How to read the order book for Aclarion Inc.2025 Risk Factors & AI Forecasted Entry and Exit Points - newser.com
Why Aclarion Inc. Equity Warrant stock could rally in 2025Earnings Recap Summary & Weekly High Return Stock Opportunities - newser.com
Is Aclarion Inc. stock positioned well for digital economyJuly 2025 Patterns & Weekly Top Stock Performers List - newser.com
Earnings visualization tools for Aclarion Inc.July 2025 PostEarnings & Weekly High Return Opportunities - newser.com
Applying chart zones and confluence areas to Aclarion Inc.Bear Alert & AI Powered Buy and Sell Recommendations - newser.com
Why Aclarion Inc. stock is trending among retail tradersJuly 2025 Reactions & Verified Stock Trade Ideas - newser.com
Visual trend scoring systems applied to Aclarion Inc.Market Activity Report & Low Risk Profit Maximizing Plans - newser.com
Aclarion Inc. Stock Analysis and ForecastDebt-to-Equity Ratio Analysis & Free Real-Time Stock Market Data - earlytimes.in
Why Aclarion Inc. Equity Warrant stock is favored by top institutions2025 Market Trends & Expert Curated Trade Ideas - newser.com
Aclarion appoints first UK commercial director as insurance coverage expands - Investing.com Nigeria
Technical signs of recovery in Aclarion Inc.Trade Ideas & AI Driven Stock Reports - newser.com
Will Aclarion Inc. Equity Warrant stock benefit from infrastructure spendingMarket Volume Summary & Safe Capital Growth Tips - newser.com
Can Aclarion Inc. Equity Warrant stock attract ESG capital inflowsAnalyst Downgrade & Expert Curated Trade Setups - newser.com
Pattern recognition hints at Aclarion Inc. Equity Warrant upsideJuly 2025 Spike Watch & Accurate Buy Signal Alerts - newser.com
Can Aclarion Inc. Equity Warrant stock withstand economic slowdownJuly 2025 Trade Ideas & Daily Risk Controlled Trade Plans - newser.com
Why hedge funds are buying Aclarion Inc. stockJuly 2025 Reactions & Low Risk Entry Point Guides - newser.com
Aclarion Inc Stock (ACON) Financials Data
Revenue
Net Income
Cash Flow
EPS
12.00%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):